Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6722-6724
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6722
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6722
Figure 1 Giant tumor with central hypoechoic area dominated the right lobe of the liver (A) and remarkable regression of tumor with obscure margin after administration of vitamin K (B).
Figure 2 Enhancement of peripheral portion of tumor during early arterial phase (A) and hypoattenuation during portal phase (B) as well as remarkable tumor regression and no enhancement during early arterial phase (C) and portal phase (D) 5 mo after administration of vitamin K.
Figure 3 Clinical course of the patient.
- Citation: Nouso K, Uematsu S, Shiraga K, Okamoto R, Harada R, Takayama S, Kawai W, Kimura S, Ueki T, Okano N, Nakagawa M, Mizuno M, Araki Y, Shiratori Y. Regression of hepatocellular carcinoma during vitamin K administration. World J Gastroenterol 2005; 11(42): 6722-6724
- URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6722.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6722